4-甲酰基-2-甲基苯硼酸频那醇酯 | 1073354-66-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-甲酰基-2-甲基苯硼酸频那醇酯
• 中文别名: 4-甲酰基-2-甲基苯基硼酸频哪醇酯
• 英文名称: 3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde
• CAS: 1073354-66-1
• 化学式: C₁₄H₁₉BO₃
• mdl: MFCD08669583
• 分子量: 246.114
• InChiKey: JUFVNKBJTLKQGA-UHFFFAOYSA-N

物化性质

• 沸点：
  358.7±35.0 °C(Predicted)
• 密度：
  1.05±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.04
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2934999090
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P330,P363,P501
• 危险性描述：
  H302,H312,H332

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Formyl-2-methylphenylboronic acid pinacol ester
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Formyl-2-methylphenylboronic acid pinacol ester
CAS number: 1073354-66-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C14H19BO3
Molecular weight: 246.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-甲酰基-2-甲基苯硼酸频那醇酯 在 甲醇 、 sodium tetrahydroborate 、 四(三苯基膦)钯 、 氯化亚砜 、 caesium carbonate 、 三乙胺 作用下， 以 1,4-二氧六环 、 二氯甲烷 、 水 、 乙腈 为溶剂， 反应 15.0h， 生成 4-(4-((2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)pyrrolidin-1-yl)methyl)-2-methylphenyl)-3-methylpyridine
  参考文献：
  名称：

  [EN] PYRROLIDINE GLYCOSIDASE INHIBITORS
  [FR] INHIBITEURS DE PYRROLIDINE GLYCOSIDASE

  摘要：

  式（I）中A、W、R3b、Z和p的含义如权利要求所述，可用于治疗tau病和阿尔茨海默病。

  公开号：

  WO2020039027A1
• 作为产物：
  描述：

  4-溴-3-甲基苯甲醛 、 联硼酸频那醇酯 在 bis-triphenylphosphine-palladium(II) chloride 、 potassium acetate 作用下， 以 1,4-二氧六环 为溶剂， 反应 8.0h， 以63%的产率得到4-甲酰基-2-甲基苯硼酸频那醇酯
  参考文献：
  名称：

  发现GSK1070916，一种Aurora B / C激酶的有效和选择性抑制剂

  摘要：

  Aurora激酶在有丝分裂的调控中起关键作用，并经常在人类肿瘤中过度表达或扩增。选择性抑制剂可能为治疗具有Aurora激酶扩增的肿瘤提供新的疗法。在这里，我们描述了基于7氮杂吲哚的系列研究中的领先优化工作，最终确定了GSK1070916（17k）。该系列进展的关键是将含有碱性胺的2-芳基引入到氮杂吲哚上，从而显着改善了细胞活性。化合物17k是具有K i的Aurora B和C的有效且选择性的ATP竞争性抑制剂*值分别为0.38±0.29和1.5±0.4 nM，并且是Aurora A的选择性> 250倍。生化特征表明，化合物17k与Aurora B的解离半衰期非常慢（> 480分钟），这与之区别开来来自临床化合物1和2。用化合物17k体外治疗A549人肺癌细胞可产生有效的抗增殖作用（EC 50 = 7 nM）。在携带人类肿瘤异种移植物的小鼠中腹膜内施用17k会导致人类结肠癌（Colo205）丝

  DOI：

  10.1021/jm901870q

文献信息

• Aryl- or Heteroaryl-Substituted Benzene Compounds
  申请人：KUNTZ KEVIN W.

  公开号：US20120264734A1

  公开（公告）日：2012-10-18

  The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

  本发明涉及芳基或杂芳基取代的苯化合物。本发明还涉及含有这些化合物的药物组合物，以及通过向需要的受试者投与这些化合物和药物组合物来治疗癌症的方法。本发明还涉及利用这些化合物进行研究或其他非治疗目的的用途。
• Photocatalytic Cross-Couplings of Aryl Halides Enabled by <i>o</i>-Phosphinophenolate and <i>o</i>-Phosphinothiophenolate
  作者：Ni Shen、Runhan Li、Can Liu、Xuzhong Shen、Wei Guan、Rui Shang

  DOI：10.1021/acscatal.1c05941

  日期：2022.3.4

  o-Phosphinophenolate and o-phosphinothiophenolate are potent photocatalysts with strong reducing ability to activate aryl chlorides and bromides under visible light for borylation, arylation, and phosphorylation. Experimental and theoretical studies revealed that the o-diphenylphosphino substituent results in a narrow optical gap and facilitates intersystem crossing to access triplet states, which

  o -Phosphinophenolate 和o -phosphinothiophenolate是有效的光催化剂，具有很强的还原能力，可在可见光下活化芳基氯化物和溴化物，进行硼化、芳基化和磷酸化。实验和理论研究表明，邻二苯基膦取代基会导致窄的光学间隙并促进系统间交叉进入三重态，从而促进酚盐和苯硫酚作为有效的可见光-光氧化还原催化剂发挥作用。本文提出的结果表明合成改性的酚盐和苯硫酚盐作为光氧化还原催化剂的前景广阔。
• Photoredox Generation of Carbon-Centered Radicals Enables the Construction of 1,1-Difluoroalkene Carbonyl Mimics
  作者：Simon B. Lang、Rebecca J. Wiles、Christopher B. Kelly、Gary A. Molander

  DOI：10.1002/anie.201709487

  日期：2017.11.20

  facile, scalable route to access functional‐group‐rich gem‐difluoroalkenes. Using visible‐light‐activated catalysts in conjunction with an arsenal of carbon‐radical precursors, an array of trifluoromethyl‐substituted alkenes undergoes radical defluorinative alkylation. Nonstabilized primary, secondary, and tertiary radicals can be used to install functional groups in a convergent manner, which would otherwise

  描述了一种方便，可扩展的途径来访问功能基团丰富的宝石-二氟烯烃。将可见光活化的催化剂与碳自由基前体库结合使用，可将三氟甲基取代的烯烃阵列进行自由基脱氟烷基化反应。不稳定的伯，仲和叔自由基可用于以汇聚方式安装官能团，否则这将受到双电子途径的挑战。该过程很容易扩展到其他全氟烷基取代的烯烃。此外，我们报告了有机三氟硼酸盐试剂的开发，以加快必要的三氟甲基取代的烯烃原料的合成。
• Aryl- or heteroaryl-substituted benzene compounds
  申请人：Epizyme, Inc.

  公开号：US08765732B2

  公开（公告）日：2014-07-01

  The present invention relates to aryl- or heteroaryl-substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

  本发明涉及芳基或杂芳基取代的苯化合物。本发明还涉及含有这些化合物的制药组合物，并通过将这些化合物和制药组合物用于需要的患者治疗癌症的方法。本发明还涉及将这些化合物用于研究或其他非治疗目的的用途。
• Substituted 6,5-fused bicyclic heteroaryl compounds
  申请人：Epizyme, Inc.

  公开号：US08962620B2

  公开（公告）日：2015-02-24

  The present invention relates to substituted 6,5-fused bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof.

  本发明涉及取代的6,5-融合的杂环芳基化合物。本发明还涉及包含这些化合物的制药组合物以及通过向需要的受试者给予这些化合物和制药组合物来治疗癌症的方法。